帕金森患者病症,深部脑刺激疗法 z-bo 2020-10-17 342

　　Researchers from Duke University School of Medicine have shown through research that, compared with young people with Parkinson's disease, the transplantation of deep brain stimulators may not pose a risk to elderly people with Parkinson's disease. Related research results were published in the international journal "JAMAeurology". Researcher Nandanad said in the article that Parkinson's disease is a common movement disorder that has disastrous consequences for the elderly. Many dyskinesias can be relieved or cured with special drugs, but as the patient gets older, the disease will worsen. The side effects of the drug may not be well controlled. These side effects include involuntary muscle movement. Therefore, deep brain stimulation (DBS) is especially important for elderly patients with Parkinson's disease.

　　This study collected and analyzed the treatment data of 1750 patients who received DBS treatment from 2000 to 2009. The results showed that 132 of them (7.5%) spent at least 90 days. After receiving deep brain stimulation treatment, complications of the treated patients included wound infection, pneumonia, hemorrhage and pulmonary embolism. Researchers say that aging does not significantly affect the overall incidence of complications in patients, and this situation is more pronounced in elderly patients undergoing surgery.

　　In our study, Dr. Lad recommended that patients and their families use DBS as a potential treatment for effective control of Parkinson's disease symptoms, which means that the scientists are older. He also said that this will help clarify the risk of complications for patients. Finally, the researchers hope that their findings will provide new research ideas and look forward to developing new treatments for Parkinson's disease.